Translate Bio announced the appointment of Ann Barbier, M.D., Ph.D., as chief medical Officer, effective immediately. Dr. Barbier brings nearly 20 years of drug discovery and development experience to Translate Bio, and will be responsible for leading all clinical research and development, medical Affairs and related functions at Translate Bio. Prior to joining Translate Bio, Dr. Barbier was vice president of clinical development, rare genetic diseases, at Agios Pharmaceuticals, where she led the development program of a small molecule in rare benign hematological diseases.